Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Revenue (2022 - 2026)

Cannabis Bioscience International Holdings' Revenue history spans 5 years, with the latest figure at $11205.0 for Q1 2026.

  • On a quarterly basis, Revenue fell 24.95% to $11205.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $123627.0, a 64.05% decrease, with the full-year FY2025 number at $303022.0, up 21.77% from a year prior.
  • Revenue hit $11205.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from $53266.0 in the prior quarter.
  • Over the last five years, Revenue for CBIH hit a ceiling of $178887.0 in Q3 2024 and a floor of $11205.0 in Q1 2026.
  • Historically, Revenue has averaged $58627.1 across 5 years, with a median of $52259.0 in 2023.
  • Biggest five-year swings in Revenue: skyrocketed 145.65% in 2024 and later crashed 86.47% in 2025.
  • Tracing CBIH's Revenue over 5 years: stood at $82581.0 in 2022, then dropped by 22.81% to $63748.0 in 2023, then increased by 16.47% to $74248.0 in 2024, then dropped by 28.26% to $53266.0 in 2025, then plummeted by 78.96% to $11205.0 in 2026.
  • Business Quant data shows Revenue for CBIH at $11205.0 in Q1 2026, $53266.0 in Q4 2025, and $24200.0 in Q3 2025.